Patent details

Herbas

VPB

Print

EN | LT

LT - Azaindazolo arba diazaindazolo tipo dariniai kaip vaistai

EN - DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE AS MEDICAMENT

Legal status

Patent lapsed (non-payment of fees)

Claims | Licences/Sublicenses

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 471/04	(2006.01)
		A61K 31/4162	(2006.01)
		A61P 35/00	(2006.01)

European patent
(11)	Number of the document	2668184
(13)	Kind of document	T
(96)	European patent application number	12701884.4
	Date of filing the European patent application	2012-01-27
(97)	Date of publication of the European application	2013-12-04
(45)	Date of publication and mention of the grant of the patent	2018-01-10
(46)	Date of publication of the claims translation	2018-04-10

PCT application
(86)	Number	PCT/EP2012/051283
	Date	2012-01-27

PCT application publication
(87)	Number	WO 2012/101239
	Date	2012-08-02

Priority applications
(30)	Number	Date	Country code
	1150651	2011-01-27	FR

Inventors
(72)	KALOUN, El Bachir, FR BEDJEGUELAL, Karim, FR RABOT, Rémi, FR KRUCZYNSKI, Anna, FR SCHMITT, Philippe, FR PEREZ, Michel, FR RAHIER, Nicolas, FR

Grantee
(73)	Pierre Fabre Médicament, 45, Place Abel Gance, 92100 Boulogne-Billancourt, FR

Attorney or representative
(74)	Marija LENKUTIENĖ, Patentinių paslaugų centras, UAB, Jono Basanavičiaus g. 11/1, LT-03108 Vilnius, LT

Title
(54)	Azaindazolo arba diazaindazolo tipo dariniai kaip vaistai
	DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE AS MEDICAMENT

Last renewal fee
	Payment date	Validity (years)	Amount
	2023-12-27	13	289.00 EUR

Legal status
	Patent lapsed (non-payment of fees)
	Invalidation date	2025-01-27